BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19051133)

  • 21. Preventing coronary heart disease and stroke with aggressive statin therapy in older adults using a team management model.
    Mason CM
    J Am Acad Nurse Pract; 2009 Jan; 21(1):47-53. PubMed ID: 19125895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of genetic variants associated with response to statin therapy.
    Mega JL; Morrow DA; Brown A; Cannon CP; Sabatine MS
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1310-5. PubMed ID: 19667110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single nucleotide polymorphisms in genes that are associated with a modified response to statin therapy: the Rotterdam Study.
    de Keyser CE; Eijgelsheim M; Hofman A; Sijbrands EJ; Maitland-van der Zee AH; van Duijn CM; Uitterlinden AG; Witteman JC; Ch Stricker BH
    Pharmacogenomics J; 2011 Feb; 11(1):72-80. PubMed ID: 20195290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice.
    Davidson MH; Gandhi SK; Ohsfeldt RL; Fox KM
    Am J Med; 2009 Jan; 122(1 Suppl):S51-9. PubMed ID: 19110088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
    Heintjes EM; Penning-van Beest FJ; Johansson S; Stalenhoef AF; Herings RM
    Curr Med Res Opin; 2009 Nov; 25(11):2621-9. PubMed ID: 19743959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Statin cuts cardiovascular risk in half].
    Einecke D
    MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacogenetics of Lipid-Lowering Agents: an Update Review on Genotype-Dependent Effects of HDL-Targetingand Statin Therapies.
    Messas N; Dubé MP; Tardif JC
    Curr Atheroscler Rep; 2017 Sep; 19(11):43. PubMed ID: 28944433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOE gene polymorphisms and response to statin therapy.
    Zintzaras E; Kitsios GD; Triposkiadis F; Lau J; Raman G
    Pharmacogenomics J; 2009 Aug; 9(4):248-57. PubMed ID: 19529002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
    Davidson M
    Am J Cardiol; 2008 Dec; 102(12A):19L-27L. PubMed ID: 19084086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid management in the geriatric patient.
    Nair AP; Darrow B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. When a statin fails.
    Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of statins on MHC class I expression.
    Singh P; Kohr D; Kaps M; Blaes F
    Ann N Y Acad Sci; 2009 Sep; 1173():746-51. PubMed ID: 19758224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Is statin treatment for children safe and effective?].
    Marchetti F; Cannioto Z
    Recenti Prog Med; 2008 Dec; 99(12):599-601. PubMed ID: 19388217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Over-the-counter statin drug.
    Roberts WC
    Am J Cardiol; 2004 Nov; 94(10):1362. PubMed ID: 15541271
    [No Abstract]   [Full Text] [Related]  

  • 35. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
    Jones PH
    Am J Cardiol; 2008 Dec; 102(12A):41L-47L. PubMed ID: 19084089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human hydroxymethylglutaryl-coenzyme A reductase (HMGCR) and statin sensitivity.
    Jawaid S; Gertz M; Corsino C; Cheung J; Seidle H; Couch RD
    Indian J Biochem Biophys; 2010 Dec; 47(6):331-9. PubMed ID: 21355415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term lipid effects of pioglitazone by baseline anti-hyperglycemia medication therapy and statin use from the PROactive experience (PROactive 14).
    Spanheimer R; Betteridge DJ; Tan MH; Ferrannini E; Charbonnel B;
    Am J Cardiol; 2009 Jul; 104(2):234-9. PubMed ID: 19576353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral neuropathy and statins.
    Prescrire Int; 2007 Dec; 16(92):247-8. PubMed ID: 18092417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statins and the colorectum: hope for chemoprevention?
    Baron JA
    Cancer Prev Res (Phila); 2010 May; 3(5):573-5. PubMed ID: 20403999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
    Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.